June 12, 2009 / 12:44 PM / in 9 years

UPDATE 1-Patheon posts smaller quarterly loss

* Q2 loss $0.04/shr vs loss of $0.09/shr a yr-ago

* Q2 revenue down 10 pct (In U.S. dollars, unless noted)

TORONTO, June 12 (Reuters) - Contract drug manufacturer Patheon Inc PTI.TO posted a smaller quarterly loss on Friday as costs and restructuring expenses declined.

The Toronto-based company, which is the target of a lengthy takeover bid by U.S. private equity firm JLL Partners Inc, said its loss narrowed to $3.2 million, or 4 cents a share, in the second quarter ended on April 30 from $8 million, or 9 cents a share, a year earlier.

Revenue fell 10 percent to $167.4 million, largely due to currency fluctuations.

Excluding dividends paid on the company’s convertible preferred shares, the company posted a quarterly profit of about $500,000.

JLL, which owns about 39 percent of outstanding restricted voting shares, launched an unsolicited bid for the company in December. (Reporting by Euan Rocha; Editing by Lisa Von Ahn)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below